logo
AF
Ami Fadia
Analyst at Leerink Partners
USA
Ticker Coverage
ALDR
Sector Coverage
Mentions in the News
Can Mylan amp up new launches by ramping up 2019 spending? Analysts aren’t so sure
If there’s one thing giving Mylan analysts pause, it’s the company’s plans to ramp up 2019 spending. It's true that the company is in the midst of rolling out several key drugs—but whether that extra outlay can pay off is the question.
Published: Feb 27 2019
Would you like to be included in the directory? Let us know!
exchange@streetcontxt.com
© Street Contxt. All Rights Reserved.
Privacy